pd 98059 has been researched along with tryptanthrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aithagani, SK; Bhushan, S; Guru, SK; Kumar, A; Kumar, S; Malik, F; Pathania, AS; Sharma, PR; Singh, PP; Vishwakarma, RA | 1 |
| Chang, HN; Chueh, HY; Pang, JS; Yeh, YC | 1 |
2 other study(ies) available for pd 98059 and tryptanthrine
| Article | Year |
|---|---|
The synthetic tryptanthrin analogue suppresses STAT3 signaling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells.
Topics: Apoptosis; Blotting, Western; Caspases; Cell Proliferation; Flavonoids; Flow Cytometry; Gene Expression Regulation; Gene Silencing; HL-60 Cells; Humans; Immunoprecipitation; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Quinazolines; RNA, Small Interfering; STAT3 Transcription Factor | 2014 |
The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells.
Topics: Angiogenesis Inhibitors; Apelin; Apelin Receptors; Flavonoids; Gene Expression Regulation; Half-Life; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Promoter Regions, Genetic; Quinazolines; RNA Stability; RNA, Messenger; Signal Transduction; Wortmannin | 2019 |